Cell Reports, Mar 13, 2024 Dr. Tarn, Woan-Yuh DDX3 regulates cancer immune surveillance via 3' UTR-mediated cell-surface expression of PD-L1 Small Methods, Mar 08, 2024 Dr. Hwang, Dennis W. A Facile NMR Method for Pre-MRI Evaluation of Trigger-Responsive T1 Contrast Enhancement Journal of Controlled Release, Feb 28, 2024 Dr. Roffler, Steve R. Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs Cell Genomics, Feb 27, 2024 Dr. Suzuki, Jun In vivo CRISPR screening directly targeting testicular cells Molecular Cell, Feb 19, 2024 Dr. Lee, Yu-Ru UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity Frontiers in Immunology, Feb 15, 2024 Dr. Chen, Shih-Yu Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness JCI Insight, Feb 06, 2024 Dr. Chang, Ya-Jen Staphylococcus aureus exacerbates dermal IL-33-ILC2 axis activation through evoking RIPK3/MLKL-mediated necroptosis of dry skin Cancers (Basel), Feb 03, 2024 Dr. Shen, Chen-Yang miR-622 Increases miR-30a Expression through Inhibition of Hypoxia-Inducible Factor 1α to Improve Metastasis and Chemoresistance in Human Invasive Breast Cancer Cells